158 related articles for article (PubMed ID: 12383369)
1. Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents.
Dumont RJ; Dayoub H; Li JZ; Dumont AS; Kallmes DF; Hankins GR; Helm GA
Neurosurgery; 2002 Nov; 51(5):1239-44; discussion 1244-5. PubMed ID: 12383369
[TBL] [Abstract][Full Text] [Related]
2. Human mesenchymal stem cells transduced with recombinant bone morphogenetic protein-9 adenovirus promote osteogenesis in rodents.
Dayoub H; Dumont RJ; Li JZ; Dumont AS; Hankins GR; Kallmes DF; Helm GA
Tissue Eng; 2003 Apr; 9(2):347-56. PubMed ID: 12740097
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy.
Alden TD; Pittman DD; Beres EJ; Hankins GR; Kallmes DF; Wisotsky BM; Kerns KM; Helm GA
J Neurosurg; 1999 Jan; 90(1 Suppl):109-14. PubMed ID: 10413134
[TBL] [Abstract][Full Text] [Related]
4. Thoracoscopic intradiscal spine fusion using a minimally invasive gene-therapy technique.
Riew KD; Lou J; Wright NM; Cheng SL; Bae KT; Avioli LV
J Bone Joint Surg Am; 2003 May; 85(5):866-71. PubMed ID: 12728037
[TBL] [Abstract][Full Text] [Related]
5. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
[TBL] [Abstract][Full Text] [Related]
6. The osteoinductive properties of Nell-1 in a rat spinal fusion model.
Lu SS; Zhang X; Soo C; Hsu T; Napoli A; Aghaloo T; Wu BM; Tsou P; Ting K; Wang JC
Spine J; 2007; 7(1):50-60. PubMed ID: 17197333
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein gene therapy for the induction of spinal arthrodesis.
Alden TD; Hankins GR; Beres EJ; Kallmes DF; Helm GA
Neurosurg Focus; 1998 Feb; 4(2):e12. PubMed ID: 17206767
[TBL] [Abstract][Full Text] [Related]
8. Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus.
Li JZ; Hankins GR; Kao C; Li H; Kammauff J; Helm GA
J Gene Med; 2003 Sep; 5(9):748-56. PubMed ID: 12950065
[TBL] [Abstract][Full Text] [Related]
9. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting.
Peterson B; Iglesias R; Zhang J; Wang JC; Lieberman JR
Spine (Phila Pa 1976); 2005 Feb; 30(3):283-9; discussion 289-90. PubMed ID: 15682007
[TBL] [Abstract][Full Text] [Related]
10. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis.
Varady P; Li JZ; Cunningham M; Beres EJ; Das S; Engh J; Alden TD; Pittman DD; Kerns KM; Kallmes DF; Helm GA
Hum Gene Ther; 2001 Apr; 12(6):697-710. PubMed ID: 11426468
[TBL] [Abstract][Full Text] [Related]
11. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent.
Helm GA; Alden TD; Beres EJ; Hudson SB; Das S; Engh JA; Pittman DD; Kerns KM; Kallmes DF
J Neurosurg; 2000 Apr; 92(2 Suppl):191-6. PubMed ID: 10763690
[TBL] [Abstract][Full Text] [Related]
12. A light and electron microscopic study of ectopic tendon and ligament formation induced by bone morphogenetic protein-13 adenoviral gene therapy.
Helm GA; Li JZ; Alden TD; Hudson SB; Beres EJ; Cunningham M; Mikkelsen MM; Pittman DD; Kerns KM; Kallmes DF
J Neurosurg; 2001 Aug; 95(2):298-307. PubMed ID: 11780901
[TBL] [Abstract][Full Text] [Related]
13. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR
J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043
[TBL] [Abstract][Full Text] [Related]
14. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
15. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model.
Hsu WK; Wang JC; Liu NQ; Krenek L; Zuk PA; Hedrick MH; Benhaim P; Lieberman JR
J Bone Joint Surg Am; 2008 May; 90(5):1043-52. PubMed ID: 18451397
[TBL] [Abstract][Full Text] [Related]
16. De novo osteogenesis from human ligamentum flavum by adenovirus-mediated bone morphogenetic protein-2 gene transfer.
Yang IH; Kim H; Kwon UH; Lee KI; Jun JA; Kim JH; Yun CO; Park SY; Lee HM; Moon SH
Spine (Phila Pa 1976); 2005 Dec; 30(24):2749-54. PubMed ID: 16371898
[TBL] [Abstract][Full Text] [Related]
17. Promoting lumbar spinal fusion by adenovirus-mediated bone morphogenetic protein-4 gene therapy.
Zhao J; Zhao DY; Shen AG; Liu F; Zhang F; Sun Y; Wu HF; Lu CF; Shi HG
Chin J Traumatol; 2007 Apr; 10(2):72-6. PubMed ID: 17371615
[TBL] [Abstract][Full Text] [Related]
18. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector.
Alden TD; Pittman DD; Hankins GR; Beres EJ; Engh JA; Das S; Hudson SB; Kerns KM; Kallmes DF; Helm GA
Hum Gene Ther; 1999 Sep; 10(13):2245-53. PubMed ID: 10498255
[TBL] [Abstract][Full Text] [Related]
19. The use of bone morphogenetic protein gene therapy in craniofacial bone repair.
Alden TD; Beres EJ; Laurent JS; Engh JA; Das S; London SD; Jane JA; Hudson SB; Helm GA
J Craniofac Surg; 2000 Jan; 11(1):24-30. PubMed ID: 11314095
[TBL] [Abstract][Full Text] [Related]
20. The use of bone morphogenetic protein-6 gene therapy for percutaneous spinal fusion in rabbits.
Laurent JJ; Webb KM; Beres EJ; McGee K; Li J; van Rietbergen B; Helm GA
J Neurosurg Spine; 2004 Jul; 1(1):90-4. PubMed ID: 15291027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
